Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Policymakers must prioritize access to innovative obesity care in tackling the obesity epidemic across the United States.

Since President Trump was sworn into office for a second term, he has proposed or initiated changes impacting Medicare.

Insulin changed the way we treat and manage diabetes. Chemotherapy has precipitously reduced the mortality rate of certain ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the federal government's Medicare program. The Centers for Medicare and Medicaid ...

Sen. Bill Cassidy reintroduced the Treat and Reduce Obesity Act (TROA) to address the obesity crisis through Medicare coverage for weight management. The bill aims to expand coverage for obesity ...

Obesity costs U.S. health care nearly $173 billion yearly. With more than 200 related complications such as heart disease, ...

Americans with obesity face almost double the financial hardship as their peers without obesity, according to a study published in Annals of Internal Medicine that highlighted not only elevated out-of ...

The May 26 front-page article “Patients face new hurdles to affordable obesity drugs ” highlighted significant barriers patients and providers face in accessing GLP-1 and dual GLP-1/GIP ...

Outgoing US President Joe Biden has proposed a dramatic expansion of Medicare coverage of obesity drugs, although it remains to be seen if it will survive under Donald Trump's new administration ...